243 related articles for article (PubMed ID: 15138811)
1. Smith-Magenis syndrome and growth hormone deficiency.
Spadoni E; Colapietro P; Bozzola M; Marseglia GL; Repossi L; Danesino C; Larizza L; Maraschio P
Eur J Pediatr; 2004 Jul; 163(7):353-8. PubMed ID: 15138811
[TBL] [Abstract][Full Text] [Related]
2. Detection and delineation of an unusual 17p11.2 deletion by array-CGH and refinement of the Smith-Magenis syndrome minimum deletion to approximately 650 kb.
Schoumans J; Staaf J; Jönsson G; Rantala J; Zimmer KS; Borg A; Nordenskjöld M; Anderlid BM
Eur J Med Genet; 2005; 48(3):290-300. PubMed ID: 16179224
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic FISH probes for del(17)(p11.2p11.2) associated with Smith-Magenis syndrome should contain the RAI1 gene.
Vlangos CN; Wilson M; Blancato J; Smith AC; Elsea SH
Am J Med Genet A; 2005 Jan; 132A(3):278-82. PubMed ID: 15690371
[TBL] [Abstract][Full Text] [Related]
4. Systemic growth hormone corrects sleep disturbance in Smith-Magenis syndrome.
Itoh M; Hayashi M; Hasegawa T; Shimohira M; Kohyama J
Brain Dev; 2004 Oct; 26(7):484-6. PubMed ID: 15351087
[TBL] [Abstract][Full Text] [Related]
5. Genotype-phenotype correlation in Smith-Magenis syndrome: evidence that multiple genes in 17p11.2 contribute to the clinical spectrum.
Girirajan S; Vlangos CN; Szomju BB; Edelman E; Trevors CD; Dupuis L; Nezarati M; Bunyan DJ; Elsea SH
Genet Med; 2006 Jul; 8(7):417-27. PubMed ID: 16845274
[TBL] [Abstract][Full Text] [Related]
6. Genes in a refined Smith-Magenis syndrome critical deletion interval on chromosome 17p11.2 and the syntenic region of the mouse.
Bi W; Yan J; Stankiewicz P; Park SS; Walz K; Boerkoel CF; Potocki L; Shaffer LG; Devriendt K; Nowaczyk MJ; Inoue K; Lupski JR
Genome Res; 2002 May; 12(5):713-28. PubMed ID: 11997338
[TBL] [Abstract][Full Text] [Related]
7. Refinement of the Smith-Magenis syndrome critical region to approximately 950kb and assessment of 17p11.2 deletions. Are all deletions created equally?
Vlangos CN; Yim DK; Elsea SH
Mol Genet Metab; 2003 Jun; 79(2):134-41. PubMed ID: 12809645
[TBL] [Abstract][Full Text] [Related]
8. RAI1 variations in Smith-Magenis syndrome patients without 17p11.2 deletions.
Girirajan S; Elsas LJ; Devriendt K; Elsea SH
J Med Genet; 2005 Nov; 42(11):820-8. PubMed ID: 15788730
[TBL] [Abstract][Full Text] [Related]
9. Smith-Magenis syndrome: report of one case.
Hou JW
Acta Paediatr Taiwan; 2003; 44(3):161-4. PubMed ID: 14521023
[TBL] [Abstract][Full Text] [Related]
10. Microdeletion on 17p11.2 in a Smith-Magenis syndrome patient with mental retardation and congenital heart defect: first report from China.
Huang C; Yang YF; Zhang H; Xie L; Chen JL; Wang J; Tan ZP; Luo H
Genet Mol Res; 2012 Aug; 11(3):2321-7. PubMed ID: 22911601
[TBL] [Abstract][Full Text] [Related]
11. Variability in clinical phenotype despite common chromosomal deletion in Smith-Magenis syndrome [del(17)(p11.2p11.2)].
Potocki L; Shaw CJ; Stankiewicz P; Lupski JR
Genet Med; 2003; 5(6):430-4. PubMed ID: 14614393
[TBL] [Abstract][Full Text] [Related]
12. Circadian rhythm abnormalities of melatonin in Smith-Magenis syndrome.
Potocki L; Glaze D; Tan DX; Park SS; Kashork CD; Shaffer LG; Reiter RJ; Lupski JR
J Med Genet; 2000 Jun; 37(6):428-33. PubMed ID: 10851253
[TBL] [Abstract][Full Text] [Related]
13. Prenatal diagnosis of Smith-Magenis syndrome in two fetuses with increased nuchal translucency, mild lateral ventriculomegaly, and congenital heart defects.
Lei TY; Li R; Fu F; Wan JH; Zhang YL; Jing XY; Liao C
Taiwan J Obstet Gynecol; 2016 Dec; 55(6):886-890. PubMed ID: 28040141
[TBL] [Abstract][Full Text] [Related]
14. Polydactyly in a boy with Smith-Magenis syndrome.
MarianneJensen L; Kirchhoff M
Clin Dysmorphol; 2005 Oct; 14(4):189-190. PubMed ID: 16155420
[TBL] [Abstract][Full Text] [Related]
15. A Turkish patient with large 17p11.2 deletion presenting with Smith Magenis syndrome.
Tug E; Cine N; Aydin H
Genet Couns; 2011; 22(1):11-9. PubMed ID: 21614983
[TBL] [Abstract][Full Text] [Related]
16. RAI1 point mutations, CAG repeat variation, and SNP analysis in non-deletion Smith-Magenis syndrome.
Bi W; Saifi GM; Girirajan S; Shi X; Szomju B; Firth H; Magenis RE; Potocki L; Elsea SH; Lupski JR
Am J Med Genet A; 2006 Nov; 140(22):2454-63. PubMed ID: 17041942
[TBL] [Abstract][Full Text] [Related]
17. Mosaicism for del(17)(p11.2p11.2) underlying the Smith-Magenis syndrome.
Juyal RC; Kuwano A; Kondo I; Zara F; Baldini A; Patel PI
Am J Med Genet; 1996 Dec; 66(2):193-6. PubMed ID: 8958329
[TBL] [Abstract][Full Text] [Related]
18. New developments in Smith-Magenis syndrome (del 17p11.2).
Gropman AL; Elsea S; Duncan WC; Smith AC
Curr Opin Neurol; 2007 Apr; 20(2):125-34. PubMed ID: 17351481
[TBL] [Abstract][Full Text] [Related]
19. Definition of the critical interval for Smith-Magenis syndrome.
Elsea SH; Purandare SM; Adell RA; Juyal RC; Davis JG; Finucane B; Magenis RE; Patel PI
Cytogenet Cell Genet; 1997; 79(3-4):276-81. PubMed ID: 9605871
[TBL] [Abstract][Full Text] [Related]
20. Neurologic and developmental features of the Smith-Magenis syndrome (del 17p11.2).
Gropman AL; Duncan WC; Smith AC
Pediatr Neurol; 2006 May; 34(5):337-50. PubMed ID: 16647992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
